MP Biomedicals, LLC launches new line of well-characterized antibodies, antigens, and ELISA kits to advance SARS-CoV-2 research
Monoclonal antibodies specific and potent against a variety of SARS-CoV-2 protein domains Wide selection of high purity SARS-CoV-2 recombinant proteins Robust and optimized ELISA kits to quantify SARS-CoV-2 virus-triggered human IgM/IgG IRVINE, Calif. , Sept. 29, 2022 /PRNewswire/ — MP…
Comments Off on MP Biomedicals, LLC launches new line of well-characterized antibodies, antigens, and ELISA kits to advance SARS-CoV-2 research